Dr. Minal Milind Dhamankar, MD

Dr. Dhamankar practices at Jefferson Einstein Montgomery Hospital in East Norriton, Pennsylvania, part of Thomas Jefferson University.

Dr. Dhamankar's NPI, 1154651917, was assigned on December 29, 2009. Dr. Dhamankar holds Pennsylvania license MD441295.

Dr. Dhamankar's primary practice is Jefferson Einstein Montgomery Hospital, at 559 West Germantown Pike, East Norriton, PA 19403 in Montgomery County. The practice phone is (484) 662-1000.

Dr. Dhamankar's primary practice is Jefferson Einstein Montgomery Hospital in East Norriton, Pennsylvania, part of Thomas Jefferson University. Dr. Dhamankar is also affiliated with Jefferson Einstein Philadelphia Hospital. The medical group on file is Einstein Gastroenterology Associates. Dmand AI also links Dr. Dhamankar to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dhamankar practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Dhamankar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Dhamankar is licensed in Pennsylvania.

CMS data shows 733 Medicare services from Dr. Dhamankar across 6 procedure codes in 2024, for 344 Medicare patients. Medicare paid $71,949 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 344 Medicare patients who saw Dr. Dhamankar in 2024. The largest group is 65 to 74, with 137 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dhamankar's median patient age at 67, with 70% women.

In 2024, Dr. Dhamankar wrote 760 Medicare Part D claims for 192 patients. 77% of them were for generic drugs. CMS names the drug for 663 of them, across 17 drugs with 11 or more claims each, at $614,216 in total drug cost. In 2023, CMS named 498 claims across 15 drugs.

Dr. Dhamankar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dhamankar as offering telehealth.

Dmand AI links 3 papers to Dr. Dhamankar, published from 2024 to 2025. Dr. Dhamankar's most frequent co-authors are Aruna Padmanabhan, MD and Shari B. Rudoler, MD.

Dmand AI links Dr. Dhamankar to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Breast Neoplasms, Breast Neoplasms, Male and Breast Diseases.

CMS Open Payments shows 41 general payments to Dr. Dhamankar from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Daiichi Sankyo Inc. paid the most, $104.